RxSight, Inc. to Report Second Quarter Financial Results on August 5, 2024
RxSight, Inc. (NASDAQ: RXST), an ophthalmic medical device company, has announced it will release its second quarter 2024 financial results on August 5, 2024, after market close. The company will host a conference call at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss the results. Interested parties can register for the call, with a recommendation to join ten minutes early to ensure proper setup. A dial-in option will be available, and the call will be live-streamed and archived for one year on the company's investor relations website.
RxSight, Inc. (NASDAQ: RXST), un'azienda di dispositivi medici oftalmici, ha annunciato che rilascerà i suoi risultati finanziari del secondo trimestre 2024 il 5 agosto 2024, dopo la chiusura del mercato. L'azienda organizzerà una conference call alle 13:30 ora del Pacifico / 16:30 ora dell'Est per discutere i risultati. Le parti interessate possono registrarsi per la chiamata, con la raccomandazione di collegarsi dieci minuti prima per garantire una configurazione adeguata. Sarà disponibile un opzione di accesso telefonico, e la chiamata sarà trasmessa in diretta e archiviata per un anno sul sito web delle relazioni con gli investitori dell'azienda.
RxSight, Inc. (NASDAQ: RXST), una empresa de dispositivos médicos oftálmicos, ha anunciado que publicará sus resultados financieros del segundo trimestre de 2024 el 5 de agosto de 2024, después del cierre del mercado. La empresa llevará a cabo una conferencia telefónica a la 1:30 p.m. Hora del Pacífico / 4:30 p.m. Hora del Este para discutir los resultados. Las partes interesadas pueden registrarse para la llamada, con la recomendación de unirse diez minutos antes para asegurar una configuración adecuada. Habrá una opción de acceso telefónico, y la llamada será transmitida en vivo y archivada por un año en el sitio web de relaciones con inversores de la empresa.
RxSight, Inc. (NASDAQ: RXST), 안과 의료 기기 회사는 2024년 2분기 재무 결과를 2024년 8월 5일, 시장 종료 후 발표할 것이라고 발표했습니다. 회사는 태평양 표준시 오후 1시 30분 / 동부 표준시 오후 4시 30분에 결과를 논의하기 위한 전화 회의를 개최할 것입니다. 관심 있는 분들은 전화를 위한 등록이 가능하며, 적절한 설정을 보장하기 위해 10분 일찍 참여할 것을 권장합니다. 전화 접속 옵션이 제공되며, 통화는 실시간 스트리밍되고 1년 동안 보관됩니다 회사의 투자자 관계 웹사이트에서.
RxSight, Inc. (NASDAQ: RXST), une entreprise spécialisée dans les dispositifs médicaux ophtalmiques, a annoncé qu'elle publiera ses résultats financiers du deuxième trimestre 2024 le 5 août 2024, après la fermeture du marché. L'entreprise organisera une conférence téléphonique à 13h30 heure du Pacifique / 16h30 heure de l'Est pour discuter des résultats. Les parties intéressées peuvent s'inscrire pour l'appel, avec la recommandation de se joindre dix minutes à l'avance pour assurer une bonne configuration. Une option de connexion par téléphone sera disponible et l'appel sera diffusé en direct et archivé pendant un an sur le site web des relations avec les investisseurs de l'entreprise.
RxSight, Inc. (NASDAQ: RXST), ein Unternehmen für ophthalmologische Medizinprodukte, hat angekündigt, dass es seine Finanzergebnisse für das zweite Quartal 2024 am 5. August 2024, nach Marktschluss, veröffentlichen wird. Das Unternehmen wird um 13:30 Uhr Pazifikzeit / 16:30 Uhr Eastern Time eine Telefonkonferenz abhalten, um die Ergebnisse zu diskutieren. Interessierte Parteien können sich für den Anruf registrieren, und es wird empfohlen, zehn Minuten früher einzuwählen, um eine ordnungsgemäße Einrichtung sicherzustellen. Eine Einwahlmöglichkeit wird zur Verfügung stehen, und der Anruf wird live gestreamt und ein Jahr lang archiviert auf der Investor Relations-Website des Unternehmens.
- None.
- None.
ALISO VIEJO, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the second quarter of 2024 after the market close on Monday, August 5, 2024. The company’s management will discuss the results during a conference call beginning at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time.
To participate in the conference call please register here. While not required, it is recommended that participants join ten minutes prior to the event start time to ensure the necessary audio applications are downloaded and installed. Instructions are provided (including a dial-in option). The call will also be available live and archived for one year at https://investors.rxsight.com/.
About RxSight, Inc.
RxSight, Inc. is an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery. The RxSight® Light Adjustable Lens system, comprised of the RxSight Light Adjustable Lens® (LAL™/LAL+™, collectively the “LAL”), RxSight Light Delivery Device (LDD™) and accessories, is the first and only commercially available intraocular lens (IOL) technology that can be adjusted after surgery, enabling doctors to customize and deliver high-quality vision to patients after cataract surgery. Additional information about RxSight can be found at www.rxsight.com.
Company Contact:
Shelley B. Thunen
Chief Financial Officer
sthunen@rxsight.com
Investor Relations Contact:
Oliver Moravcevic
VP, Investor Relations
omoravcevic@rxsight.com
FAQ
When will RxSight (RXST) report its Q2 2024 financial results?
What time is RxSight's (RXST) Q2 2024 earnings conference call?
How can I participate in RxSight's (RXST) Q2 2024 earnings call?
Where can I access the archived version of RxSight's (RXST) Q2 2024 earnings call?
